Applied Molecular Evolution's IPO

Applied Molecular Evolution raised a round of funding on July 27, 2000. Investors include Public.

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME's…

Articles about Applied Molecular Evolution's IPO: